Hydroxylated boswellic and glycyrrhetinic acid derivatives: synthesis and cytotoxicity
AbstractOxidation of 2,3-dehydro-11-keto--boswellic acid gave derivatives holding extra hydroxyl groups at positions C-1, C-2 or C-1 and C-9, respectively. The synthesis of 2,3-dehydro-1,9-dihydroxy-11-keto--boswellic acid represents the first partial-synthetic access to this class of compounds. The synthetic strategy can be expanded easily, and a corresponding analogue derived from glycyrrhetinic acid was accessed by the same synthetic scheme in good overall yield. Boswellic and glycyrrhetinic acid 1,9-endoperoxides are intermediates for the synthesis of the 1,9-dihydroxylated compounds. These 1,9-endo-peroxides were highly cytotoxic for several human tumor cell lines but only diminished cytotoxicity was observed in SRB assays for the 1,9-dihydroxylated compounds.
- M. Abdel-Tawab, O. Werz, M. Schubert-Zsilavecz, Boswellia serrata; an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data, Clin. Pharmacokinet. 2011, 50, 349-369.
- Z. Du, Z. Liu, Z. Ning, Y. Liu, Z. Song, C. Wang, A. Lu, Prospects of Boswellic Acids as Potential Pharmaceutics, Planta Med. 2015, 81, 259-271.
- T. Morikawa, H. Matsuda, M. Yoshikawa, A review of anti-inflammatory terpenoids from the incense gum resins frankincense and myrrh, J. Oleo Sci. 2017, 66, 805-814.
- A. Moussaieff, R. Mechoulam, Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials, J. Pharm. Pharmacol. 2009, 61, 1281-1293.
- A. Sharma, S. Chhikara, S. N. Ghodekar, S. Bhatia, M. D. Kharya, V. Gajbhiye, A. S. Mann, A. G. Namdeo, K. R. Mahadik, Phytochemical and pharmacological investigations on Boswellia serrata, Pharmacogn. Rev. 2009, 3, 195-204.
- A. Al-Harrasi, H. Hussain, R. Csuk, Y. K. Khan, Chemistry and bioactivity of boswellic acids and other terpenoids of the genus boswellia; Elsevier, 2018.
- H. P. T. Ammon, Boswellic Acids and Their Role in Chronic Inflammatory Diseases, Adv. Exp. Med. Biol. 2016, 928, 291-327.
- H. Hussain, A. Al-Harrasi, R. Csuk, U. Shamraiz, I. R. Green, I. Ahmed, I. A. Khan, Z. Ali, Therapeutic potential of boswellic acids: a patent review (1990-2015), Expert Opin. Ther. Pat. 2017, 27, 81-90.
- M. A. Khan, R. Ali, R. Parveen, A. K. Najmi, S. Ahmad, Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata, J. Ethnopharmacol. 2016, 191, 315-323.
- R. Paduch, M. Kandefer-Szerszen, Antitumor and Antiviral Activity of Pentacyclic Triterpenes, Mini-Rev. Org. Chem. 2014, 11, 262-268.
- H. P. T. Ammon, Boswellic acids in chronic inflammatory diseases, Planta Med. 2006, 72, 1100-1116.
- S. C. Ng, Y. T. Lam, K. K. F. Tsoi, F. KL. L. Chan, J. J. Y. Sung, J. C. Y. Wu, Systematic review: the efficacy of herbal therapy in inflammatory bowel disease, Aliment. Pharmacol. Ther. 2013, 38, 854-863.
- C. Anthoni, M. G. Laukoetter, E. Rijcken, T. Vowinkel, R. Mennigen, S. Müller, N. Senninger, J. Russell, J. Jauch, J. Bergmann, D. N. Granger, C. F. Krieglstein, Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis, Am. J. Physiol. 2006, 290, G1131-G1137.
- P. R. Kiela, A. J. Midura, N. Kuscuoglu, S. D. Jolad, A. M. Solyom, D. G. Besselsen, B. N. Timmermann, F. K. Ghishan, Effects of boswellia serrata in mouse models of chemically induced colitis, Am. J. Physiol. 2005, 288, G798-G808.
- A. Sarkate, S. S. DhaneshwarInvestigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation, World J. Gastroenterol. 2017, 23, 1147-1163.
- S. S. Sonje, D. N. Raut, S. R. Chaudhari, M. J. Chavan, Effect of Boswellia serrata Extract Microcapsule Against Ulcerative Colitis in Mice, Nat. Prod. J. 2016, 6, 305-312.
- U. Siemoneit, B. Hofmann, N. Kather, T. Lamkemeyer, J. Madlung, L. Franke, G. Schneider, J. Jauch, D. Poeckel, O. Werz, Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids, Biochem. Pharmacol. 2008, 75, 503-513.
- U. Siemoneit, C. Pergola, B. Jazzar, H. Northoff, C. Skarke, J. Jauch, O. Werz, On the interference of boswellic acids with 5-lipoxygenase: Mechanistic studies in vitro and pharmacological relevance, Eur. J. Pharmacol. 2009, 606, 246-254.
- U. Siemoneit, L. Tausch, D. Poeckel, M. Paul, H. Northoff, A. Koeberle, J. Jauch, O. Werz, Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata Extracts, Planta Med. 2017, 83, 1020-1027.
- R. Csuk, A. Barthel-Niesen, A. Barthel, R. SchÃ¤fer, A. Al-Harrasi, 11-Keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells, Eur. J. Med. Chem. 2015, 100, 98-105.
- R. Csuk, A. Niesen-Barthel, A. Barthel, R. Kluge, D. Ströhl, D. Synthesis of an antitumor active endoperoxide from 11-keto-Î²-boswellic acid, Eur. J. Med. Chem. 2010, 45, 3840-3843.
- R. Csuk, A. Niesen-Barthel, R. Schäfer, A. Barthel, A. Al-Harrasi, Synthesis and antitumor activity of ring A modified 11-keto-Î²-boswellic acid derivatives, Eur. J. Med. Chem. 2015, 92, 700-711.
- P. Fan, T. Li, Y. Ye, Q. Luo, H. Yuan, H. Lou, Synthesis and cytotoxic activity of boswellic acid analogues, Phytochem. Lett. 2016, 18, 99-104.
- A. Kumar, A. Qayum, P. R. Sharma, S. K. Singh, B. A. Shah, Synthesis of β-boswellic acid derivatives as cytotoxic and apoptotic agents, Bioorg. Med. Chem. Lett. 2016, 26, 76-81.
- T. Li, P. Fan, Y. Ye, Q. Luo, H. Lou, Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity, Anti-Cancer Agents Med. Chem. 2017, 17, 1153-1167.
- K. Li, L. Li, S. Wang, X. Li, T. Ma, D. Liu, Y. Jing, L. Zhao, Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability, Eur. J. Med. Chem. 2017, 126, 910-919.
- H. Schneider, M. Weller, M. Boswellic acid activity against glioblastoma stem-like cells, Oncol. Lett. 2016, 11, 4187-4192.
- R. K. Wolfram, L. Fischer, R. Kluge, D. Ströhl, A. Al-Harrasi, R. Csuk, Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans, Eur. J. Med. Chem. 2018, 155, 869-879.
- H. Huang, A. Li, F. Zhao, X. Xie, K. Li, Y. Jing, D. Liu, L. Zhao, Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin 1 inhibitors with remarkable anti-prostate cancer activity, Bioorg. Med. Chem. Lee. 2018, 28, 3187-3193.
- B. Meka, S. R. Ravada, M. K. K. Muthyala, K. P. Nagasree, T. Golakoti, Synthesis of new analogs of AKBA and evaluation of their anti-inflammatory activity, Bioorg. Med. Chem. 2017, 25, 1374-1388.
- S. Shen, X. Xu, Z. Liu, J. Liu, L. Hu, Synthesis and structure-activity relationships of boswellic acid derivatives as potent VEGFR-2 inhibitors, Bioorg. Med. Chem. 1993, 23, 1982-1993.
- A. Kumar, B. A. Shah, S. Singh, A. Hamid, S. K. Singh, V. K. Sethi, A. K. Saxena, J. Singh, S. C. Taneja, Acyl derivatives of boswellic acids as inhibitors of NF-ï«B and STATs, Bioorg. Med. Chem. Lett. 2012, 22, 431-435
- B. Mahajan, S. C. Taneja, V. K. Sethi, K. L. Dhar, Two triterpenoids from Boswellia serrata gum resin, Phytochemistry 1995, 39, 453-455.
- S. Schweizer, A. F. W. Von Brocke, S: E. Boden, E. Bayer, H. P. T. Ammon, H. Safayhi, Workup-Dependent Formation of 5-Lipoxygenase Inhibitory Boswellic Acid Analogues, J. Nat. Prod. 2000, 63, 1058-1061.
- A. Al-Harrasi, N. U. Rehman, A. L. Khan, M. Al-Broumi, I. Al-Amri, H. Hussain, J. Hussain, R. Csuk, Chemical, molecular and structural studies of Boswellia species: β-Boswellic Aldehyde and 3-epi-11β-Dihydroxy BA as precursors in biosynthesis of boswellic acids, PLoS One 2018, 13, e0198666.
- J. Jauch, J. Bergmann, Chemical of boswellic acids, 1. An efficient method for the large-scale preparation of 3-O-acetyl-11-oxo-Î²-boswellic acid and other boswellic acids, Eur. J. Org. Chem. 2003, 4752-4756.
- R. Csuk, A. Barthel-Niesen, D. Ströhl, R. Kluge, C. Wagner, A. Al-Harrasi, Oxidative and reductive transformations of 11-keto-β-boswellic acid, Tetrahedron 2015, 71, 2025-2034.
- V. Kulcitki, N. Ungur, M. Gavagnin, M. Carbone, G. Cimino, Further synthetic studies towards the austrodorane skeleton: Synthesis of austrodoral, Eur. J. Org. Chem. 2005, 1816-1822.
- J. Baeten, K. Deforce, S. Challe, D. Vos, P. de Degryse, Holy smoke in medieval funerary rites: chemical fingerprints of frankincense in Southern Belgian incense burners, PLoS One 2014, 9, e113142/1-e113142/18, 18 pp.
- O. Werz, J.-F. Kapp, R. Martin, Use of boswellic acids and synthetic boswellic acid derivatives for inhibiting microsomal prostaglandin E2 synthase and cathepsin G, WO2009117987A3.
- O. Werz, U. Siemoneit, A. Henkel, J. Jauch, N. Kather, Use of boswellic acids and synthetic boswellic acid derivatives for inhibiting microsomal prostaglandin E2 synthase and cathepsin G, DE102008015607A1.
- J. Jauch, Simple method for the synthesis of boswellic acids and derivatives thereof, WO2002085921A2.
- A. Chung, M. R. Miner, K. J. Richert, C. J. Rieder, K. A. Woerpel, Formation of an Endoperoxide upon Chromium-Catalyzed Allylic Oxidation of a Triterpene by Oxygen, J. Org. Chem. 2015, 80, 266-273.
- A. Niesen, A. Barthel, R. Kluge, A. Köwitsch, D. Ströhl, S. Schwarz, R. Csuk, Antitumoractive Endoperoxides from Triterpenes, Arch. Pharm. 2009, 342, 569-576.
- S. Schwarz, R. Csuk, R. Synthesis and antitumour activity of glycyrrhetinic acid derivatives, Bioorg. Med. Chem. 2010, 18, 7458-7474.
- S. He, W. Yang, L. Zhu, G. Du, C.-S. Lee, Bioinspired Total Synthesis of (±)-Yezo'otogirin C, Org. Lett. 2014, 16, 496-499.
- Y. Kara, M. Balci, A new and stereospecific synthesis of an inositol analogue: bis-homoinositol, Tetrahedron 2003, 59, 2063-2066.
- M. S. Alam, G. Kaur, A. Ali, H. Hamid, M. Ali, M. Athar, Two new bioactive oleanane triterpene glycosides from Terminalia arjuna, Nat. Prod. Res. 2008, 22, 1279-1288.
- A. Ali, M. Ali, M. S. Alam, Two new oleanane triterpene glycosides from the bark of Terminalia arjuna, Z. Naturforsch., B: Chem. Sci. 2006, 61, 1282-1286.
- R. A. Kaskoos, M. Ali, K. J. Naquvi, New homosesquiterpenol and stigmasteryl digalactoside from the stem bark of Terminalia arjuna, Int. Res. J. Pharm. 2012, 3, 137-139.
- R. A. Kaskoos, M. Ali, K. J. Naquvi, New oleanene triterpenoids from the stem bark of Terminalia arjuna, J. Pharm. Res. 2012, 5, 2368-2372.
- P. Skehan, R, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 1990, 82, 1107-1112.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).